Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.
about
Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta-analysis.
P2860
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@ast
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@en
type
label
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@ast
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@en
prefLabel
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@ast
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@en
P2093
P2860
P356
P1476
Ezetimibe/simvastatin 10/40 mg ...... controlled, multicenter study.
@en
P2093
Andrei Gheorghe Dan
Celine Le Bailly De Tilleghem
Christopher Milardo
Fernando Civeira
Joseph Triscari
Mary E Hanson
Paul Kah Hing Ling
Rachid Massaad
P2860
P2888
P356
10.1186/1476-511X-11-18
P577
2012-01-31T00:00:00Z
P6179
1035777741